145 related articles for article (PubMed ID: 37011503)
1. Trans-cinnamaldehyde attenuates renal ischemia/reperfusion injury through suppressing inflammation via JNK/p38 MAPK signaling pathway.
Chen L; Yuan J; Li H; Ding Y; Yang X; Yuan Z; Hu Z; Gao Y; Wang X; Lu H; Cai Y; Bai Y; Pan X
Int Immunopharmacol; 2023 May; 118():110088. PubMed ID: 37011503
[TBL] [Abstract][Full Text] [Related]
2. The Ischemia and Reperfusion Injury Involves the Toll-Like Receptor-4 Participation Mainly in the Kidney Cortex.
Herrera-Luna Y; Lozano M; Pasten C; Multhoff G; Irarrázabal CE
Cell Physiol Biochem; 2022 Nov; 56(6):613-628. PubMed ID: 36378153
[TBL] [Abstract][Full Text] [Related]
3. Increasing expression of dual-specificity phosphatase 12 mitigates oxygen-glucose deprivation/reoxygenation-induced neuronal apoptosis and inflammation through inactivation of the ASK1-JNK/p38 MAPK pathway.
He J; Li S; Teng Y; Xiong H; Wang Z; Han X; Gong W; Gao Y
Autoimmunity; 2024 Apr; 57(1):2345919. PubMed ID: 38721693
[TBL] [Abstract][Full Text] [Related]
4. Pretreatment with a novel Toll-like receptor 4 agonist attenuates renal ischemia-reperfusion injury.
Hernandez A; Patil NK; Brewer M; Delgado R; Himmel L; Lopez LN; Bohannon JK; Owen AM; Sherwood ER; de Caestecker MP
Am J Physiol Renal Physiol; 2023 May; 324(5):F472-F482. PubMed ID: 36995924
[TBL] [Abstract][Full Text] [Related]
5. EZH2 plays a crucial role in ischemia/reperfusion-induced acute kidney injury by regulating p38 signaling.
Liang H; Huang Q; Liao MJ; Xu F; Zhang T; He J; Zhang L; Liu HZ
Inflamm Res; 2019 Apr; 68(4):325-336. PubMed ID: 30820607
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation.
Jiang M; Li J; Peng Q; Liu Y; Liu W; Luo C; Peng J; Li J; Yung KK; Mo Z
J Neuroinflammation; 2014 Sep; 11():167. PubMed ID: 25256700
[TBL] [Abstract][Full Text] [Related]
7. Pantoprazole Attenuates MAPK (ERK1/2, JNK, p38)-NF-κB and Apoptosis Signaling Pathways after Renal Ischemia/Reperfusion Injury in Rats.
Fawzy MA; Maher SA; Bakkar SM; El-Rehany MA; Fathy M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639009
[TBL] [Abstract][Full Text] [Related]
8. Maslinic Acid Attenuates Ischemia/Reperfusion-Induced Acute Kidney Injury by Suppressing Inflammation and Apoptosis Through Inhibiting NF-κB and MAPK Signaling Pathway.
Sun W; Choi HS; Kim CS; Bae EH; Ma SK; Kim SW
Front Pharmacol; 2022; 13():807452. PubMed ID: 35496304
[TBL] [Abstract][Full Text] [Related]
9. TBC1Domain Family Member 25 deficiency aggravates cerebral ischemia-reperfusion injury via TAK1-JNK/p38 pathway.
Zhang Z; Ma T; Fu Z; Feng Y; Wang Z; Tian S; Liu Z; Wei W; Li X; Chen J; Zhao W
J Neurochem; 2022 Feb; 160(3):392-411. PubMed ID: 34837397
[TBL] [Abstract][Full Text] [Related]
10. CXCL16/ROCK1 signaling pathway exacerbates acute kidney injury induced by ischemia-reperfusion.
Liang H; Liao M; Zhao W; Zheng X; Xu F; Wang H; Huang J
Biomed Pharmacother; 2018 Feb; 98():347-356. PubMed ID: 29275176
[TBL] [Abstract][Full Text] [Related]
11. Effect of ulinastatin on myocardial ischemia-reperfusion injury through JNK and P38 MAPK signaling pathways.
Yang ZH; Lu YJ; Gu KP; Xiang ZY; Huang HM
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8658-8664. PubMed ID: 31646600
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of IL-1β/p38 mitogen activated protein kinase pathway by diacerein protects against kidney ischemia/reperfusion injury in rats.
El-Aziz Fathy EA; Abdel-Gaber SA; Gaber Ibrahim MF; Thabet K; Waz S
Cytokine; 2024 Apr; 176():156511. PubMed ID: 38290257
[TBL] [Abstract][Full Text] [Related]
13. Role of GADD45A in myocardial ischemia/reperfusion through mediation of the JNK/p38 MAPK and STAT3/VEGF pathways.
Wang Y; Gao H; Cao X; Li Z; Kuang Y; Ji Y; Li Y
Int J Mol Med; 2022 Dec; 50(6):. PubMed ID: 36331027
[TBL] [Abstract][Full Text] [Related]
14. PIM1 attenuates renal ischemia-reperfusion injury by inhibiting ASK1-JNK/P38.
Luo Y; Zhu J; Zhao F; Shi L; Li Y; Wu X
Int Immunopharmacol; 2023 Jan; 114():109563. PubMed ID: 36513021
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats.
Yeda X; Shaoqing L; Yayi H; Bo Z; Huaxin W; Hong C; Zhongyuan X
Acta Cir Bras; 2017 Jun; 32(6):429-439. PubMed ID: 28700004
[TBL] [Abstract][Full Text] [Related]
16. Regulator of G-protein signaling 14 protects the liver from ischemia-reperfusion injury by suppressing TGF-β-activated kinase 1 activation.
Zhang JK; Ding MJ; Liu H; Shi JH; Wang ZH; Wen PH; Zhang Y; Yan B; Guo DF; Zhang XD; Tao RL; Yan ZP; Zhang Y; Liu Z; Guo WZ; Zhang SJ
Hepatology; 2022 Feb; 75(2):338-352. PubMed ID: 34455616
[TBL] [Abstract][Full Text] [Related]
17. Neohesperidin dihydrochalbazone protects against septic acute kidney injury in mice.
Yang R; Qi L; Liang W
Phytomedicine; 2023 Feb; 110():154623. PubMed ID: 36608504
[TBL] [Abstract][Full Text] [Related]
18. Nilotinib protects the murine liver from ischemia/reperfusion injury.
Ocuin LM; Zeng S; Cavnar MJ; Sorenson EC; Bamboat ZM; Greer JB; Kim TS; Popow R; DeMatteo RP
J Hepatol; 2012 Oct; 57(4):766-73. PubMed ID: 22641092
[TBL] [Abstract][Full Text] [Related]
19. Role of p38 MAPK, Akt and NFκB in renoprotective effects of nebivolol on renal ischemia-reperfusion injury in rats.
Cavdar Z; Kocak A; Ural C; Afagh A; Ersan S; Ozbal S; Tatli M; Celik A; Arslan S; Cavdar C
Biotech Histochem; 2023 Nov; 98(6):401-411. PubMed ID: 37211827
[TBL] [Abstract][Full Text] [Related]
20. Lrg1 silencing attenuates ischemia-reperfusion renal injury by regulating autophagy and apoptosis through the TGFβ1- Smad1/5 signaling pathway.
Chen J; Zhang Z; Feng L; Liu W; Wang X; Chen H; Zou H
Arch Biochem Biophys; 2024 Mar; 753():109892. PubMed ID: 38246328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
